SiRIC-Curie supports the emergence of new teams at the heart of the translational research department
The support of SiRIC-Curie comes in two different forms:
- Emerging teams : Emerging teams develop themes which fall within one of SIRIC Curie programs. They gather a certain number of researchers and physicians around an important biomedical question. SiRIC-Curie contributes support in the form of the funding of a key PI or post doctorant position whose aim is to structure the project. Recruitment is carried out by an international call. Emerging teams are systematically interviewed by the international scientific advisory board
- Mature teams : Mature teams, labelled SiRIC-Curie “new translational research teams” address significant biomedical questions. They are headed by physician-researchers or researchers with a strong foundation in clinical research. The teams are identified with an international call and are selected after an audition by the SiRIC-Curie scientific advisory board. The creation of these teams is supported by a starting grant for five years
All of the teams are located at the heart of the translational research department in the hospital. They benefit from the proximity to the department’s platforms and the patents and industrial partnerships department. All the teams have been recruited through an international competitive call and have been evaluated by the SiRIC-Curie international scientific advisory board.
SiRIC-Curie endorsed teams
Three international calls were published ; one in 2013, one in 2014 and the last in 2015 for the endorsement of the new translational research teams.
Following a very competitive selection and after recommendations from the SiRIC-Curie scientific advisory board three candidates were selected for the excellence of their projects and received the SIRIC « new translational research teams » label.
- Translational Research in Pediatric Onocology Team (RTOP)
Gudrun Schleiermacher (Franck Bourdeaut, Co-PI)
- Residual Tumor and Response to Treatment Team (RT²)
- Translational Research in Immunotherapy (TransIm)
Eliane Piaggio (Delphine Loirat, Co-PI)
- Dynamic modelling of epigenetic plasticity in cancer
- Integrative functional genomics of cancer (IFGC)
The teams are led by a physician/researcher (MD-PhD) or by a physician and researcher duo. The teams advocate a project or theme that attempts to reply to an unresolved medical need.
These teams are supported by a tranverse thematic group within the hospital and they are linked to a research unit. They benefit from the accompaniment of an external mentor who is recognised for his expertise in the domain. The teams are regularly evaluated.